Add To Cart

Section 2
Risks: Effectiveness of Medications
to Treat Opioid Use Disorder

Question 2 | Test | Table of Contents

National Institute on Drug Abuse 

If you wish to increase the text size of this publication, maximize your window.
Click outside the box below, press Ctrl “+” several times, then scroll.
Questions? Email: info@mentalhealthce.com

- National Institute on Drug Abuse. (June 2018). Medications to Treat Opioid Use Disorder Research Report. National Institute on Drug Abuse, p. 4-10.

Update
The Role of Pharmacogenomics
in Opioid Prescribing

- Wong, A. K., Somogyi, A. A., Rubio, J., & Philip, J. (2022). The Role of Pharmacogenomics in Opioid Prescribing. Current treatment options in oncology, 23(10), 1353–1369. https://doi.org/10.1007/s11864-022-01010-x

Peer-Reviewed Journal Article References:
Chavez, M. N., & Rigg, K. K. (2020). Nutritional implications of opioid use disorder: A guide for drug treatment providers. Psychology of Addictive Behaviors, 34(6), 699–707.

Evans, A. C., Jr. (2020). Testimony on the inadequate federal approach to opioid treatment and the need to expand care. Professional Psychology: Research and Practice, 51(1), 5–9.

Oliva, E. M., Bowe, T., Tavakoli, S., Martins, S., Lewis, E. T., Paik, M., Wiechers, I., Henderson, P., Harvey, M., Avoundjian, T., Medhanie, A., & Trafton, J. A. (2017). Development and applications of the Veterans Health Administration’s Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psychological Services, 14(1), 34–49. 

QUESTION 2
What are three medications that also increase the likelihood that a person will remain in treatment, which itself is associated with a lower risk of overdose mortality, reduced risk of HIV and HCV transmission, reduced criminal justice involvement, and greater likelihood of employment? To select and enter your answer go to Test
.


Test
Section 3
Table of Contents
Top